121 related articles for article (PubMed ID: 36354717)
1. Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer.
Mittmann N; Seung SJ; Diong C; Gatley JM; Wolfson M; Guertin MH; Pashayan N; Simard J; Chiarelli AM
Curr Oncol; 2022 Oct; 29(11):8330-8339. PubMed ID: 36354717
[TBL] [Abstract][Full Text] [Related]
2. Organized breast screening improves reattendance compared to physician referral: a case control study.
Makedonov I; Gu S; Paszat LF;
BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
[TBL] [Abstract][Full Text] [Related]
3. Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program.
Gold N; Christensen RAG; Arneja J; Aminoleslami A; Anderson GM; Brooks JD
Breast Cancer Res Treat; 2023 Apr; 198(3):523-533. PubMed ID: 36800117
[TBL] [Abstract][Full Text] [Related]
4. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
[TBL] [Abstract][Full Text] [Related]
6. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.
Mittmann N; Blackmore KM; Seung SJ; Diong C; Done SJ; Chiarelli AM
Curr Oncol; 2023 Sep; 30(9):8550-8562. PubMed ID: 37754535
[TBL] [Abstract][Full Text] [Related]
7. Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.
Habbous S; Homenauth E; Barisic A; Kandasamy S; Majpruz V; Forster K; Yurcan M; Chiarelli AM; Groome P; Holloway CMB; Eisen A
CMAJ Open; 2022; 10(2):E313-E330. PubMed ID: 35383035
[TBL] [Abstract][Full Text] [Related]
8. False-positive result and reattendance in the Ontario Breast Screening Program.
Chiarelli AM; Moravan V; Halapy E; Majpruz V; Mai V; Tatla RK
J Med Screen; 2003; 10(3):129-33. PubMed ID: 14561264
[TBL] [Abstract][Full Text] [Related]
9. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the influence of clinical breast examination reports on the interpretation of mammograms in a breast screening program. Ontario Breast Screening Program Radiologists Research Group.
Knight JA; Libstug AR; Moravan V; Boyd NF
Breast Cancer Res Treat; 1998 Mar; 48(1):65-71. PubMed ID: 9541190
[TBL] [Abstract][Full Text] [Related]
11. Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program.
Blackmore KM; Chiarelli AM; Mirea L; Mittmann N; Muradali D; Rabeneck L; Done SJ
Can Assoc Radiol J; 2022 Aug; 73(3):524-534. PubMed ID: 35068172
[No Abstract] [Full Text] [Related]
12. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
[TBL] [Abstract][Full Text] [Related]
13. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
[TBL] [Abstract][Full Text] [Related]
15. Comparison of image quality indicators among mammography facilities in Ontario.
Ford NL; Yaffe MJ
Can Assoc Radiol J; 2001 Dec; 52(6):369-72. PubMed ID: 11780545
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an intervention designed to recruit Canadian women to mammography screening.
Hanson K; Montgomery P; Bakker D; Conlon M
J Community Health Nurs; 2011 Jul; 28(3):130-43. PubMed ID: 21809929
[TBL] [Abstract][Full Text] [Related]
17. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
[TBL] [Abstract][Full Text] [Related]
18. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
[TBL] [Abstract][Full Text] [Related]
19. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
Halapy EE; Chiarelli AM; Klar N; Knight J
J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
[TBL] [Abstract][Full Text] [Related]
20. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
